{
     "PMID": "14512852",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20040114",
     "LR": "20071114",
     "IS": "0959-4965 (Print) 0959-4965 (Linking)",
     "VI": "14",
     "IP": "13",
     "DP": "2003 Sep 15",
     "TI": "Protective effect of erythropoietin in neonatal hypoxic ischemia in mice.",
     "PG": "1757-61",
     "AB": "The effect of systemic erythropoietin pretreatment on hypoxic ischemic injury was examined in neonatal mice. Injury was significantly less in cortex, hippocampus, striatum and thalamus of erythropoietin-treated animals (5 U/g vs vehicle) 24 h after hypoxic ischemia and in all of these regions except hippocampus at 7 days. Activated caspase-3- and activated NFkappaB-immunoreactive neurons were observed in the injured areas; these areas were smaller in the erythropoietin group. To our knowledge, this is the first report demonstrating persistent neuroprotective effects of erythropoietin in neonatal mice.",
     "FAU": [
          "Matsushita, Hiroko",
          "Johnston, Michael V",
          "Lange, Mary S",
          "Wilson, Mary Ann"
     ],
     "AU": [
          "Matsushita H",
          "Johnston MV",
          "Lange MS",
          "Wilson MA"
     ],
     "AD": "Kennedy Krieger Research and Johns Hopkins School of medicine, Baltimore, MD 21205, USA. Matsushita@kennedykrieger.org",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 NS 28208/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "England",
     "TA": "Neuroreport",
     "JT": "Neuroreport",
     "JID": "9100935",
     "RN": [
          "0 (NF-kappa B)",
          "0 (Neuroprotective Agents)",
          "11096-26-7 (Erythropoietin)",
          "EC 3.4.22.- (Casp3 protein, mouse)",
          "EC 3.4.22.- (Caspase 3)",
          "EC 3.4.22.- (Caspases)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/*drug effects/metabolism/*pathology",
          "Caspase 3",
          "Caspases/metabolism",
          "Cerebral Cortex/drug effects/pathology",
          "Corpus Striatum/drug effects/pathology",
          "Erythropoietin/metabolism/*therapeutic use",
          "Hippocampus/drug effects/pathology",
          "Hypoxia-Ischemia, Brain/*drug therapy/metabolism/pathology",
          "Immunohistochemistry",
          "Mice",
          "Mice, Inbred Strains",
          "NF-kappa B/metabolism",
          "Neuroprotective Agents/therapeutic use",
          "Thalamus/drug effects/pathology",
          "Time Factors"
     ],
     "EDAT": "2003/09/27 05:00",
     "MHDA": "2004/01/15 05:00",
     "CRDT": [
          "2003/09/27 05:00"
     ],
     "PHST": [
          "2003/09/27 05:00 [pubmed]",
          "2004/01/15 05:00 [medline]",
          "2003/09/27 05:00 [entrez]"
     ],
     "AID": [
          "10.1097/01.wnr.0000086250.76504.71 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuroreport. 2003 Sep 15;14(13):1757-61. doi: 10.1097/01.wnr.0000086250.76504.71.",
     "term": "hippocampus"
}